Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function
Crossref DOI link: https://doi.org/10.1007/s00280-015-2878-5
Published Online: 2015-10-03
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tan, Antoinette R.
Sarantopoulos, John
Lee, Lucy
Reyderman, Larisa
He, Yi
Olivo, Martin
Goel, Sanjay
Funding for this research was provided by:
Eisai Inc
License valid from 2015-10-03